Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 657.50 GBp
Change Today 0.00 / 0.00%
Volume 7.1K
As of 11:35 AM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

craneware plc (CRW) Snapshot

657.50 GBp
Previous Close
657.50 GBp
Day High
657.50 GBp
Day Low
657.50 GBp
52 Week High
05/13/15 - 682.50 GBp
52 Week Low
01/7/15 - 475.00 GBp
Market Cap
Average Volume 10 Days
0.20 GBp
Shares Outstanding
14.56 GBp
Dividend Yield
Current Stock Chart for CRANEWARE PLC (CRW)

Related News

No related news articles were found.

craneware plc (CRW) Related Businessweek News

No Related Businessweek News Found

craneware plc (CRW) Details

Craneware plc engages in the development, licensing, and ongoing support of computer software for the United States healthcare industry. The company offers access management and strategic pricing products comprising InSight Medical Necessity, which provides medical necessity validation for payors and advance beneficiary notice creation; Pricing Analyzer software that simplifies the price modeling process; and Patient Charge Estimator software, which simplifies the process of providing patient bill estimates for inpatient and outpatient services. It also provides revenue cycle management solutions that primarily consist of Chargemaster Toolkit, Bill Analyzer, and Physician Revenue Toolkit that enhance reimbursement, efficiency, and compliance to ensure and sustain revenue integrity; and supply management solutions, including Pharmacy ChargeLink and Supplies ChargeLink, which maintains a connection between pharmaceutical and supply purchases and billing. The company’s audit and revenue recovery software products comprise InSight Audit, a Web-based audit management tool to manage claim audits and workflow from one central location; InSight Payment Variance Analyzer, which identifies, tracks, and helps eliminate revenue lost in the form of underpaid claims; and InSight Denials that analyses, tracks, trends, and reports on denial data. In addition, it provides supporting modules comprising Online Reference Toolkit, a Web-based tool for reducing risk by providing access to reference and regulatory resources; Interface Scripting Module that automatically uploads chargemaster changes to the patient billing system; and recovery audit contractor (RAC) audit services to manage various tasks related to Medicare RAC audits. Further, the company offers companion implementation and consulting services. Craneware plc was founded in 1999 and is based in Scotland, United Kingdom.

200 Employees
Last Reported Date: 03/10/15
Founded in 1999

craneware plc (CRW) Top Compensated Officers

Co-Founder, Chief Executive Officer and Execu...
Total Annual Compensation: $332.2K
Chief Financial Officer, Company Secretary an...
Total Annual Compensation: $312.8K
Compensation as of Fiscal Year 2014.

craneware plc (CRW) Key Developments

Craneware plc Enhances Corporate Chargemaster Management Solution

Craneware plc announced new enhancements to its corporate chargemaster management solution, Chargemaster Corporate Toolkit. The new features deepen the solution's enterprise functionality to help provider organizations achieve revenue integrity across multiple facilities and departments. Some of the new enterprise-class features of Chargemaster Corporate Toolkit announced include: a single consolidated view of chargemaster management efforts across the organization and the ability to quickly identify and resolve inconsistencies at the corporate, facility and department levels; streamlined functionality for pushing corporate chargemaster changes to facilities within the hospital system and keeping them synchronized, increasing efficiency and enforcing corporate standards; and integrated with Craneware's advanced workflow functionality to provide flexibility and control over the chargemaster maintenance process.

Craneware and Amerinet Renew and Grow Strategic Partnership

Craneware and Amerinet have renewed and expanded their partnership agreement through 2018. According to a release, under the terms of the agreement, Amerinet's membership base, which includes more than 82,000 provider organizations across the U.S., will have access to Craneware solutions at a discounted price. Craneware also said it will offer Amerinet members its medical necessity verification tool, InSight Medical Necessity, which gives provider organizations real-time access to medical necessity and prior authorization policies to flag upfront compliance issues. Since the companies first partnered in 2005, Craneware has been Amerinet's sole provider of chargemaster review software. Now with this extended agreement, Amerinet members will continue to have access to Craneware's Chargemaster Toolkit, Chargemaster Corporate Toolkit, Online Reference Toolkit, Bill Analyzer, Interface Scripting Module, Pharmacy ChargeLink, Patient Charge Estimator and Physician Revenue Toolkit, and will also now have access to Supplies ChargeLink, Pricing Analyzer, InSight Audit, InSight Medical Necessity and InSight Denials.

Craneware plc Proposes Interim Dividend, Payable on April 24, 2015; Reports Consolidated Unaudited Earnings Results for the Six Months Ended December 31, 2014

The Board of Craneware plc has resolved to pay an interim dividend of 6.3 pence against per ordinary share in the company on 24 April 2015 to those shareholders on the register as at 27 March 2015 against interim dividend of 5.7 pence paid a year ago. The ex-dividend date is 26 March 2015. The interim dividend of 6.3 pence per share is capable of being paid in US dollars subject to a shareholder having registered to receive their dividend in US dollars under the company's dividend currency election, or who has registered to do so by the close of business on 27 March 2015. The exact amount to be paid will be calculated by reference to the exchange rate to be announced on 27 March 2015. The interim dividend referred to above in US dollars of 9.8 cents is given as an example only using the Balance Sheet date exchange rate of $1.56/£1 and may differ from that finally announced. The company reported consolidated unaudited earnings results for the six months ended December 31, 2014. For the six months, the company reported revenue of $21,573,000 against $21,146,000 a year ago. Operating profit was $5,213,000 against $4,765,000 a year ago. Adjusted EBITDA was $6,293,000 against $5,703,000 a year ago. Profit before taxation was $5,254,000 against $4,796,000 a year ago. Profit for the period attributable to owners of the parent was $3,994,000 against $3,573,000 a year ago. Diluted earnings per share were $0.148 against $0.132 per share a year ago. Adjusted diluted earnings per share were $0.164 against $0.132 per share a year ago. Net cash from operating activities was $10,595,000 against $3,449,000 a year ago. Purchase of plant and equipment were $74,000 against $254,000 a year ago. Capitalized intangible assets was $110,000 against $61,000 a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRW:LN 657.50 GBp 0.00

CRW Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CRW.
View Industry Companies

Industry Analysis


Industry Average

Valuation CRW Industry Range
Price/Earnings 31.0x
Price/Sales 6.4x
Price/Book 6.2x
Price/Cash Flow 26.0x
TEV/Sales 6.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CRANEWARE PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at